Article thumbnail

Daidzein Prevents the Increase in CD4+CD28null T Cells and B Lymphopoesis in Ovariectomized Mice: A Key Mechanism for Anti-Osteoclastogenic Effect

By Abdul Malik Tyagi, Kamini Srivastava, Kunal Sharan, Dinesh Yadav, Rakesh Maurya and Divya Singh

Abstract

Estrogen deficiency leads to an upregulation of TNF-α producing T cells and B-lymphopoesis which augments osteoclastogenesis. Estrogen deficiency also increases the population of premature senescent CD4+CD28null T cells which secrete a higher amount of TNF-α thus leading to enhanced osteoclastogenesis. Isoflavonoids like daidzein and genistein are found mostly in soybeans, legumes, and peas. These share structural similarity with 17β-stradiol (E2) and have osteoprotective role. This study explores the effect of daidzein (Daid) on the proliferation of TNF-α producing T cells, premature senescent T cells and B cell lymphopoesis under estrogen deficient conditions. For this study adult Balb/c mice were treated with Daid at 10 mg/kg body weight dose by oral gavage daily post ovariectomy (Ovx). After six weeks animals were autopsied and bone marrow and spleen cells were collected for FACS analysis. Blood serum was collected for ELISA. It was observed that Ovx mice treated with Daid for six weeks show reduction in Ovx induced expansion of CD4+ T cells in bone marrow and spleen when analysed by flow cytometry. Estrogen deficiency led to increased prevalence of TNF-α secreting CD4+CD28null T cells, however, treatment with Daid increased the percentage of CD4+CD28+ T cells. Co-culture of CD4+CD28null T cells and bone marrow resulted in enhanced osteoclastogenesis as evident by increased tartarate resistant acid phosphatase (TRAP) expression, an osteoclast marker. However, treatment with Daid resulted in reduced osteoclastogenesis in CD4+CD28null T cells and bone marrow cell co-culture. Daid also regulated B lymphopoesis and decreased mRNA levels of RANKL in B220+ cells. Taken together, we propose that one of the mechanisms by which Daid prevents bone loss is by reversing the detrimental immune changes as a result of estrogen deficiency

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3120851
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2003). A crucial role for thiol antioxidants in estrogen-deficiency bone loss.
  2. (2009). Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis.
  3. (2007). Age-related changes in the occurrence and characteristics of thymic CD4(+) CD25(+) T cells in mice.
  4. (2006). B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.
  5. (2005). B cells and osteoblast and osteoclast development.
  6. (1999). CD4(+)T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice.
  7. (1994). Collagenase distension, two-step sequential filtration, and histopaque gradient purification for consistent isolation of pure pancreatic islets from the market-age (6-month-old) pig.
  8. (2000). Daidzein is more efficient than genistein in preventing ovariectomyinduced bone loss in rats.
  9. (1994). Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence.
  10. (2003). Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.
  11. (2003). Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies.
  12. (2006). Doseresponse study of effect of oleuropein, an olive oil polyphenol, in an ovariectomy/inflammation experimental model of bone loss in the rat.
  13. (2001). Down-regulation of CD28 expression by TNF-alpha.
  14. (2000). Effects of raloxifene, a selective estrogen receptor modulator, on thymus, T cell reactivity, and inflammation in mice.
  15. (2008). Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis.
  16. (2003). Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.
  17. (1994). Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow.
  18. (2005). Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells.
  19. (2002). Genistein, a soybean isoflavone, affects bone marrow lymphopoiesis and prevents bone loss in castrated male mice.
  20. (2001). High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women.
  21. (2002). Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women.
  22. (1993). In vitro morpho-functional analysis of pancreatic islets isolated from the domestic chicken.
  23. (1997). Increased Blymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency.
  24. (2002). Interaction of phytoestrogens with estrogen receptors alpha and beta (II).
  25. (1997). Loss of CD28 expression on T lymphocytes: a marker of replicative senescence.
  26. (2005). Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis.
  27. (1999). Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence.
  28. (2002). Molecular basis for the loss of CD28 expression in senescent T cells.
  29. (2000). Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.
  30. (1993). Ovariectomy-induced bone loss and the hematopoietic system.
  31. (2007). Ovariectomy-induced bone loss occurs independently of B cells.
  32. (2007). Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation.
  33. (2008). Oxidative stress, free radicals and bone remodeling.
  34. (2011). Premature T Cell Senescense in Ovx Mice is Inhibited by Repletion of Estrogen and Medicarpin: A Possible Mechanism for Alleviating Bone Loss. Osteoporos
  35. (1998). Prenylflavonoids: a new class of non-steroidal phytoestrogen (Part 2). Estrogenic effects of 8-isopentenylnaringenin on bone metabolism.
  36. (2009). Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats.
  37. (1998). Replicative senescence: impact on T cell immunity in the elderly. Aging (Milano)
  38. (1999). Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency.
  39. (2001). Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women.
  40. (2008). Soy isoflavones and immunity.
  41. (1997). Suppression of lectin, alloantigen, and xenoantigen-induced T-cell proliferation by Genistein.
  42. (2004). T cell senescense: a culprit of immune abnormalities in chronic inflammation and persistent infection.
  43. (2007). T cells and post menopausal osteoporosis in murine models.
  44. (1990). T lymphocyte surface antigen markers in osteoporosis.
  45. (2007). The bone-protective effect of the phytoestrogen genistein is mediated via ER alpha-dependent mechanisms and strongly enhanced by physical activity.
  46. (2005). The role of T lymphocytes in bone metabolism.
  47. (2010). The soy isoflavone equol enhances antigen-specific IgE production in ovalbuminimmunized BALB/c mice.
  48. Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction.
  49. (2001). Upregulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo.
  50. (2002). Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women.